—

Resources & Links:

📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.

💼 Work with Dr. Matt:
Looking for a keynote speaker or strategic advisor?
Visit: drsarahmatt.com

🔗 Connect on Social:
LinkedIn: https://www.linkedin.com/in/sarahmattmd/
YouTube: www.youtube.com/@DrSarahMatt

📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup

—
Disclaimer:
The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.

When an AI tool causes a patient harm, who gets called into the review meeting?

In almost every health system, the answer is the physician. The same physician who was brought into the procurement conversation as a validator after the vendor had already completed four executive demos, built the business case, and received board approval.

That is not a governance design. That is liability assignment after the fact. And it is one of the most expensive mistakes health systems are making in AI right now.

In this episode, Dr. Sarah Matt makes the case for what actual physician leadership in AI procurement looks like — and what the distinction is between being invited to validate a decision already made and having genuine authority over the clinical risk embedded in that decision.

The argument matters practically: health systems that build physician leadership into AI procurement at the authority level, not the validator level, move faster on AI implementation, not slower. Clinical buy-in is not a late-stage change management problem. It is an early-stage governance design decision.

Dr. Matt draws on her experience advising health systems and physician executives who have found themselves accountable for outcomes they did not control, in tools they did not select, for deployments they were brought into after the strategic architecture was already set.

This episode is for physician executives, CMOs, CMIOs, CNOs, and clinical leaders who are currently in, or about to enter, AI procurement conversations — and for the health system CEOs and boards who want to understand why physician leadership in AI keeps underperforming and what the structural fix requires.

What you will take away from this episode:

• The difference between physician validation and physician authority in AI procurement
• Why organizations that build genuine physician authority into AI governance move faster, not slower
• What the accountability gap looks like when something goes wrong, and how to close it before deployment
• The specific organizational design decisions that determine whether physician executives can succeed or are structurally set up to fail

—

Resources & Links:

📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.

💼 Work with Dr. Matt:
Looking for a keynote speaker or strategic advisor?
Visit: drsarahmatt.com

🔗 Connect on Social:
LinkedIn: https://www.linkedin.com/in/sarahmattmd/
YouTube: www.youtube.com/@DrSarahMatt

📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup

—
Disclaimer:
The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.

Health systems are signing AI contracts they cannot govern. That is the real problem. Not the technology.

In this episode, Dr. Sarah Matt, physician executive and healthcare strategy advisor, breaks down the three governance layers where AI deployment fails in health systems — and why organizations that conflate technology procurement with organizational readiness are setting themselves up for expensive, very public failures.

The strategic layer: who actually owns the AI portfolio, and what happens when that answer is "nobody in particular." The operational layer: why AI pilots that succeed in a controlled environment die on contact with real clinical workflows. The clinical layer: who is accountable when an AI recommendation contributes to a patient harm event — and whether your organization has that answer in writing before deployment, or is planning to figure it out afterward.

Dr. Matt draws on direct experience working with health systems navigating AI procurement, implementation failures, and the organizational redesign required to make these tools actually function. The argument she makes is not anti-AI. It is pro-governance. Health systems that build the organizational infrastructure before the contract signature will move faster, perform better, and retain clinical trust longer than those that are still building it after something goes wrong.

This episode is built for CMOs, CMIOs, CNOs, physician executives, and health system leaders who are being asked to put their professional credibility behind AI deployment and want a precise framework for what has to be in place before they do.

What you will take away from this episode:

• The three-layer governance framework for clinical AI deployment
• Why operational AI governance is a workflow problem, not a technology problem
• What named clinical accountability actually requires, and why committees are not a substitute
• The single question that reveals whether your organization is governance-ready before you sign

If you are making AI investment decisions in a health system this year, this episode is the pre-work.

—

Resources & Links:

📖 Get the Book: "The Borderless Healthcare Revolution" is available now on Amazon and major retailers.

💼 Work with Dr. Matt:
Looking for a keynote speaker or strategic advisor?
Visit: drsarahmatt.com

🔗 Connect on Social:
LinkedIn: https://www.linkedin.com/in/sarahmattmd/
YouTube: www.youtube.com/@DrSarahMatt

📧 Subscribe to The Briefing: drsarahmatt.com/newsletter-signup

—
Disclaimer:
The views expressed on this podcast are those of Dr. Sarah Matt and her guests. They do not necessarily reflect the official policy or position of any affiliated institutions. This content is for informational and educational purposes only and does not constitute medical advice or a professional consulting relationship.